"We hope this is only the beginning," UNCIEF says after securing the first delivery of malaria vaccines.

 


The first ever supply of a malaria vaccine, with a potential value of $170 million, has been given to the pharmaceutical company GSK by the United Nations Children's Fund (UNICEF) as part of its effort to combat malaria.

The UN agency claimed that this historic donation would make 18 million doses of RTS, S available over the next three years, potentially saving thousands of lives annually.

The deployment of the vaccines, according to Etleva Kadilli, director of the UN agency's supply division, is a signal to the vaccine creators to keep up their work because the vaccines are needed and wanted.

Kadilli declared: "We're hoping this is just the start. To expand supply and enable a more robust vaccination industry, continued innovation is required to produce new and next-generation vaccines. As part of a larger malaria preventive and control program, this is a huge step forward in our combined efforts to save children's lives and lessen the burden of malaria "said PTI.

The child welfare agency claims that this contract is the outcome of 18 months of careful planning and collaboration on the part of others. The malaria vaccine is expected to be in high demand in the affected countries.

RTS, S is the result of 35 years of research and development and is the first-ever vaccine against a parasite disease. The vaccine offers defense against Plasmodium falciparum, the type of malaria that primarily affects Africa and is responsible for the worst cases worldwide.

The vaccine can provide additional malaria protection to about 25 million children annually in more than 30 countries with moderate to high malaria transmission as its accessibility rises.

Comments

Popular posts from this blog

"Tomato flu" outbreak in India

Does washing garments take out monkeypox? What to be aware of cleaning for the infection

Idli and Dosa Batter: Secrets to Soft Idlies and Crispy Dosas